Lamis Eldjerou
Impact in
-
- CAR-T cell therapy research
-
- Hematopoietic Stem Cell Transplantation
Papers in
- Oncology 14
- CAR-T cell therapy research 10
-
- Hematopoietic Stem Cell Transplantation 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- John R. Wingard (3 shared papers)Yanni Hao (3 shared papers)Helen Leather (1 shared paper)Hidefumi Hiramatsu (3 shared papers)William B. Slayton (3 shared papers)Juliet N. Barker (2 shared papers)Mai He (2 shared papers)Glenn Heller (1 shared paper)
- Journals
- Blood (7 papers)Journal of Clinical Oncology (2 papers)Transfusion (2 papers)Cancer Research (1 paper)Current Opinion in Hematology (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Lamis Eldjerou
22 papers receiving 255 citations
Peers
Comparison fields: 5 of 44
- Oncology 178
- Hematology 65
- Transplantation 8
- Genetics 28
- Immunology 55
Countries citing papers authored by Lamis Eldjerou
This map shows the geographic impact of Lamis Eldjerou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lamis Eldjerou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lamis Eldjerou more than expected).
Fields of papers citing papers by Lamis Eldjerou
This network shows the impact of papers produced by Lamis Eldjerou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lamis Eldjerou. The network helps show where Lamis Eldjerou may publish in the future.
Co-authors
The 25 scholars most cited alongside Lamis Eldjerou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas. | 2020 | 41 |
| 2 | 2021 | 39 | |
| 3 | 2010 | 33 | |
| 4 | 2017 | 25 | |
| 5 | 2011 | 18 | |
| 6 | 2012 | 15 | |
| 7 | 2019 | 11 | |
| 8 | 2019 | 11 | |
| 9 | 2017 | 10 | |
| 10 | 2020 | 9 | |
| 11 | Economic Burden of Neurologic Toxicities Associated with Treatment of Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in the United States. | 2020 | 7 |
| 12 | 2024 | 7 | |
| 13 | 2015 | 6 | |
| 14 | 2019 | 5 | |
| 15 | 2021 | 5 | |
| 16 | 2018 | 5 | |
| 17 | 2008 | 4 | |
| 18 | 2014 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2019 | 2 |
About Lamis Eldjerou
Lamis Eldjerou is a scholar working on Oncology, Hematology, Molecular Biology, Genetics and Physiology, having authored 22 papers that have together received 260 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Acute Lymphoblastic Leukemia research (3 papers), Virus-based gene therapy research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Biomedical Ethics and Regulation (3 papers), Mesenchymal stem cell research (2 papers), Protein Degradation and Inhibitors (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Oncology (178 citations), Hematology (65 citations), Transplantation (8 citations), Genetics (28 citations) and Immunology (55 citations). Lamis Eldjerou has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include John R. Wingard, Yanni Hao, Helen Leather, Hidefumi Hiramatsu, William B. Slayton, Juliet N. Barker, Mai He, Glenn Heller, Richard J. O’Reilly and Sonali Chaudhury. Their work appears in journals such as Blood, Journal of Clinical Oncology, Transfusion, Cancer Research and Current Opinion in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.